General
Sickest coronavirus patients to be treated with arthritis drugs after study finds reduction in death rates
A study has found treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces the amount of time patients need intensive care.
Key points:
- The study involved 800 severely ill COVID-19 patients
- The UK Government said the drugs will be used to treat critically ill COVID-19 patients
- Results showed that on average, patients treated with Actemra or Kevzara recovered more swiftly
The findings, which have not yet been peer-reviewed, showed that the immunosuppressive drugs — Actemra, also known as tocilizumab, and Kevzara, also known as sarilumab — reduced death rates by 8.5 percentage points among patients hospitalised and severely ill with the pandemic…
-
Noosa News5 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
Noosa News11 hours agoFarmer Fred Perry’s 30-year conservation project creates bird haven after years of ‘bashing and burning’
-
General11 hours agoBoy dies after being trapped between rocks off NSW beach
-
Noosa News11 hours agoDetectives continue to search for answers on Crystal Beale’s death